[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371668-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371668-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nr4a3-suppresses-bladder-cancer-progression-by-modulating-autophagy-via-the-pi3kaktmtor-pathway","NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway","","Bladder cancer (BC) is a prevalent and aggressive malignancy with high recurrence. Autophagy can suppress tumors early but later enhance survival. NR4A3, known for tumor-suppressive effects in other cancers, is investigated in BC. TCGA analyses and clinical validation show NR4A3 is downregulated, while NR4A3 overexpression inhibits proliferation, migration, invasion, and promotes apoptosis by increasing autophagy markers and suppressing PI3K/AKT/mTOR signaling; autophagy blockade reverses these effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nr4a3-suppresses-bladder-cancer-progression-by-modulating-autophagy-via-the-pi3kaktmtor-pathway/371668/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nr4a3-suppresses-bladder-cancer-progression-by-modulating-autophagy-via-the-pi3kaktmtor-pathway/371668.png","ImageObject",300,407,{"name":42,"@type":43},"Đào","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is NR4A3 expression evaluated in bladder cancer in this study?","Question",{"text":63,"@type":64},"NR4A3 expression is assessed using TCGA data and validated in clinical BC samples with immunohistochemistry and RT-qPCR.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What functional effects does NR4A3 overexpression have on bladder cancer cells?",{"text":68,"@type":64},"NR4A3 overexpression inhibits cell proliferation, migration, and invasion and promotes apoptosis in NR4A3-overexpressing BC cell lines.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the relationship between NR4A3, autophagy, and the PI3K/AKT/mTOR pathway?",{"text":72,"@type":64},"NR4A3 overexpression increases autophagy markers and suppresses PI3K/AKT/mTOR signaling, and autophagy inhibition reverses these effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371668,1791106770,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","European Journal of Histochemistry 2025; volume 69:4221  \nNR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway  \nLi Fan,* Feng Xu,* Shouyong Liu, Ding Wu, Suchun Wan, Xin Pan, Yulin Zhou, Le Qu, Wenquan Zhou  \nDepartment of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China  \n*These authors have contributed equally to this work.  \nABSTRACT  \nBladder cancer (BC) is a prevalent and aggressive malignancy with high recurrence. Autophagy plays a dual role in cancer, acting as a tumor suppressor early on and promoting survival in later stages. NR4A3, a nuclear receptor with tumor-suppressive effects in other cancers, has not been explored in BC. NR4A3 expression was analyzed using TCGA data and validated in clinical BC samples via immunohistochemistry and RT-qPCR. NR4A3-overexpressing BC cell lines (5637, T24) were created using lentiviral vectors. Cell viability, proliferation, migration, and invasion were assessed through CCK-8, EdU, and Transwell assays. Autophagy was measured by microtubule-associated protein 1A/1B-light chain 3 (LC3), autophagy-related protein 5 (ATG5), Beclin-1 and p62 expression via immunofluorescence and Western blotting. The phosphoinositide 3-kinase (PI3K) / protein kinase B (AKT) / mammalian target of rapamycin (mTOR) pathway was examined by assessing phosphorylation levels. It was found that NR4A3 was significantly downregulated in BC tissues. Overexpression of NR4A3 inhibited BC cell proliferation, migration, and invasion, while promoting apoptosis. NR4A3 overexpression increased autophagy markers and suppressed PI3K/AKT/mTOR signaling. Autophagy inhibition reversed these effects. In conclusion, NR4A3 suppresses BC progression by promoting autophagy via the PI3K/AKT/mTOR pathway. Targeting NR4A3-mediated autophagy may provide a novel therapeutic strategy for BC.  \nKey words: bladder cancer; NR4A3; autophagy; PI3K/Akt/mTOR pathway; tumor suppressor.  \nCorrespondence: Wenquan Zhou, Department of Urology, Jinling Hospital, Medical School of Nanjing University, No.  \n305 East Zhongshan Road, Nanjing 210002, Jiangsu, [China. E-mail: Zwquan866jnh@163.com](China. E-mail: Zwquan866jnh@163.com)  \n[Contributions:](Contributions: LF)[ LF](Contributions: LF), FX, LQ, XFZ, experimental design, analysis and interpretation of data, manuscript writing; SYL, DW, SHW, XP, YLZ, contribution to development of methodology and acquisition of data; WQZ, QL, contribution to development study supervision, writing, review, and revision of the manuscript. All the authors read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.  \nConflict of interest: the authors declare no competing interests, and all authors confirm accuracy.  \nEthics approval: the experimental protocols in this study were approved by the Clinical Ethics Committee of PLA  \nEastern Theater Command General Hospital (Approval Number: 2023DZKY-037-01) .  \nAvailability of data and materials: the datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.  \n[European Journal of Histochemistry 2025; 69:4221]  \nArticle  \nIntroduction  \nBladder cancer (BC) ranks among the most prevalent urogenital malignancies, with over 550,000 new cases annually and a mortality rate exceeding 40% . 1,2 Its high recurrence and asymptomatic early stages complicate timely diagnosis and treatment, underscoring the need to elucidate molecular drivers of progression and identify novel therapeutic targets.3  \nAutophagy -a lysosome-mediated recycling process- plays dual roles in cancer: suppressing tumorigenesis by clearing damaged organelles in early stages, yet promoting survival in advanced disease.4-6 In BC, elevated autophagy facilitates invasion and chemoresistance. Studies demonstrate that silencing autophagyrelated genes (e.g., ATG7) induces apoptosis, highlighting its","cbCaia91g37xBY8p","https://ap.wps.com/l/cbCaia91g37xBY8p","pdf",6457512,"English","# Introduction\n## Autophagy in cancer and bladder cancer\n## NR4A3 and hypothesized mechanism\n# Materials and Methods\n## Bioinformatics analysis\n## Collection of clinical samples","[{\"question\":\"How is NR4A3 expression evaluated in bladder cancer in this study?\",\"answer\":\"NR4A3 expression is assessed using TCGA data and validated in clinical BC samples with immunohistochemistry and RT-qPCR.\"},{\"question\":\"What functional effects does NR4A3 overexpression have on bladder cancer cells?\",\"answer\":\"NR4A3 overexpression inhibits cell proliferation, migration, and invasion and promotes apoptosis in NR4A3-overexpressing BC cell lines.\"},{\"question\":\"What is the relationship between NR4A3, autophagy, and the PI3K/AKT/mTOR pathway?\",\"answer\":\"NR4A3 overexpression increases autophagy markers and suppresses PI3K/AKT/mTOR signaling, and autophagy inhibition reverses these effects.\"}]","NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K/AKT/mTOR pathway | PDF",1790192573,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90aac1664a05e12dc56abd3d788ccc22.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50868c48365d8f77d403e092fd8a1586.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68b997b62720b71a20a67b3c1f8bdfb3.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15f8036cf67f33a87c64357555309d61.webp",980,1306]